Correlation Between Trevi Therapeutics and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Lyra Therapeutics, you can compare the effects of market volatilities on Trevi Therapeutics and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Lyra Therapeutics.
Diversification Opportunities for Trevi Therapeutics and Lyra Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Trevi and Lyra is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Trevi Therapeutics and Lyra Therapeutics
Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 1.28 times more return on investment than Lyra Therapeutics. However, Trevi Therapeutics is 1.28 times more volatile than Lyra Therapeutics. It trades about -0.14 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.34 per unit of risk. If you would invest 436.00 in Trevi Therapeutics on November 2, 2024 and sell it today you would lose (46.00) from holding Trevi Therapeutics or give up 10.55% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Trevi Therapeutics vs. Lyra Therapeutics
Performance |
| Timeline |
| Trevi Therapeutics |
| Lyra Therapeutics |
Trevi Therapeutics and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Trevi Therapeutics and Lyra Therapeutics
The main advantage of trading using opposite Trevi Therapeutics and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Trevi Therapeutics vs. Cue Biopharma | Trevi Therapeutics vs. AN2 Therapeutics | Trevi Therapeutics vs. Bioatla | Trevi Therapeutics vs. Spero Therapeutics |
| Lyra Therapeutics vs. CytomX Therapeutics | Lyra Therapeutics vs. Assembly Biosciences | Lyra Therapeutics vs. Achilles Therapeutics PLC | Lyra Therapeutics vs. Instil Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |